Hypertrust Patient Data Care (HPDC) has launched its extended Hypertrust X-Chain supply chain management solution for Advanced & Personalized Therapies (APT). The company states that it is the first solution that allows biotech and pharmaceutical companies to design, set up, plan, orchestrate, operate and scale APT supply chains with one single system.
The new applications added to Hypertrust X-Chain are:
Hypertrust X-Chain can be implemented as an all-in-one supply chain management solution or flexibly with a focus on specific modules to complement existing system landscapes.
HPDC adds that different modules of Hypertrust X-Chain are combinable, configurable, and scalable to manage end-to-end supply chain needs across all therapy life cycle phases, from the clinical phase up to post-commercialization.
Click to enlarge.
How Industry Stakeholders View Medicare Advantage Expansion for Patients with Kidney Disease
July 7th 2025A qualitative study explores how MA plan leaders, kidney care managers, and dialysis providers perceive the benefits, risks, and marketing practices surrounding MA enrollment for patients with end-stage kidney disease.
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
July 2nd 2025As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.